New Treatment Paradigms for Advanced Melanoma

EP. 1: Considerations for Surgery in Melanoma

July 26th 2018

EP. 2: Molecular Testing in Melanoma: BRAF and PD-L1

July 26th 2018

EP. 3: Adjuvant Therapy Options in Melanoma

July 26th 2018

EP. 4: Adjuvant Therapy in Melanoma: Safety and Efficacy

July 26th 2018

EP. 5: Initiating Adjuvant Therapy in Stage 3 Melanoma

July 26th 2018

EP. 6: Melanoma: BRAF/MEK-Inhibitors as Adjuvant Therapy

July 26th 2018

EP. 7: Managing Recurrence After Adjuvant Therapy in Melanoma

July 26th 2018

EP. 8: Treating BRAF-Mutated Metastatic Melanoma

July 26th 2018

EP. 9: Anti PD-1 Therapy in Metastatic Melanoma

July 26th 2018

EP. 10: Considerations for T-VEC Therapy in Metastatic Melanoma

July 26th 2018

EP. 11: Managing Brain Mets in Melanoma

July 26th 2018

EP. 12: Managing Disease Progression in Metastatic Melanoma

July 26th 2018

EP. 13: Potential Role of Neoadjuvant Therapy in Melanoma

July 26th 2018

EP. 14: The COLUMBUS Trial in Melanoma

July 26th 2018

EP. 15: Emerging Combination Regimens in Advanced Melanoma

July 26th 2018

EP. 16: Future Outlook: Treating Advanced Melanoma

July 26th 2018

EP. 17: Molecular Testing in Stage 3 Melanoma

July 26th 2018

EP. 18: Adjuvant Therapy for Melanoma: Novel Treatment Options

July 26th 2018

EP. 19: Using Adjuvant Therapy in Patients With Melanoma

July 26th 2018

EP. 20: Considerations Surrounding Adjuvant Therapy in Melanoma

July 26th 2018

NEXT PAGE
PREVIOUS PAGE
x